Pakistan BF Biosciences Limited, a leading biopharmaceutical company, has announced the launch of its innovative product Zeptide® (Tirzepatide) in an easy-to-use pre-filled syringe format, marking a major step forward in the fight against diabetes and obesity in Pakistan. In a disclosure to the Pakistan Stock Exchange (PSX) under Sections 96 and 131 of the Securities … Continue reading BF Biosciences Launches Zeptide® for Diabetes and Obesity Treatment